Pituitary adenomas obtained from 6 patients with acromegaly and 8 patients with chromophobe adenoma were subjected to the tissue culture to correlate in vitro secretion of growth hormone (GH) and prolactin (PRL) to preoperative in vivo endocrine studies and endocrinilogical manifestations.
Tokyo 162 and 2Dept. of Neurological Surgery, Neurological Institute Tokyo Women's Medical College, Tokyo 162, Japan Synopsis Pituitary adenomas obtained from 6 patients with acromegaly and 8 patients with chromophobe adenoma were subjected to the tissue culture to correlate in vitro secretion of growth hormone (GH) and prolactin (PRL) to preoperative in vivo endocrine studies and endocrinilogical manifestations.
Tissue culture demonstrated that all of the acromegalic tumors secreted large amounts of GH for 2-4 weeks and some of the PRL-secreting chromophobe adenoma without any clinical and endocrinological evidences of GH secretion secreted considerable amounts of GH; however, no recognizable GH secretion was noted in the remaining chromophobe adenomas. PRL was secreted in vitro in large amounts by tumors obtained from patients with hyperprolactinemia with and without acromegaly. It is interesting to note that tumors obtained from 2 patients who showed very slight elevation of plasma PRL of less than 40ng/ml secreted large amounts of PRL in vitro. This finding suggests that PRL-secreting adenoma could not be ruled out in patients with mild hyperprolactinemia. The duration of in vitro PRL release was longer than that of GH and its rate of decrease was slower than that of GH.
The availability of radioimmunoassay for prolactin (PRL) in recent years has led previous observations to conclude that a high proportion of pituitary adenomas are secreting PRL (Friesen et al., 1972) . Zimmerman et al.(1974) , Frantz et al. (1972) and Guyda et al.(1973) also observed that some of the acromegalic tumors secreted PRL together with growth hormone (GH). We have performed monolayer tissue culture of adenoma tissues obtained from 14 patients with pituitary adenoma and studied in vitro secretion of GH and PRL in individual tumors with various endocrinological manifestations. These findings were compared with preoperative in vivo endocrine studies.
Materials and Methods
Six patients with acromegaly and 8 patients with chromophobe adenoma were subjected to the studies ( 
Results
The dilution curves of culture media were parallel to the standard curves of both GH and PRL (Figs. 1 and 2). adenoma. Plasma PRL levels were high in 2 patients with acromegaly (patients 1 and 6) and in 2 patients with chromophobe adenoma (patients 7 and 13). Plasma PRL levels were slightly elevated in a patient with acromegaly (patient 2) and in a patient with chromophobe adenoma (patient 8). The responses of PRL to TRH in these 2 patients were completely normal. The remaining patients had normal or low levels of PRL with normal or low responses to TRH. Changes in the concentration of GH in tissue culture media plotted as a function of time on a semilogarithmic scale are shown in Fig. 3 . GH concentrations in culture media were higher than 1,000ng/ml in all acromegalic patients and as high as 100ng/ml in 2 patients with chromophobe adenoma with hyperprolactinemia (patients 7 and 8). The remaining patients with chromophobe adenoma with and without hyperprolactinemia had low initial GH concentrations of less than 10ng/ml.
GH concentrations in the culture media of the acromegalic patients decreased rapidly in a pattern approximating straight lines on a semilogarithmic scale as in Fig. 3 until 12 to 40 days when GH decreased to less than 10ng/ml. The change in GH concentrations in the media in 2 patients with chromophobe adenoma with high initial levels followed the same pattern as that of the acromegalics. The changes in the concentrations of PRL in tissue culture media plotted as a function of time on a semilogarithmic scale are shown in Fig. 4 . PRL concentrations in the media in 6 patients with various degrees of hyperprolactinemia were as high as 100-1,000ng/ml at the beginning of the culture. PRL concentrations in the media did not correlate with preoperative plasma PRL levels among these six patients with hyperprolactinemia.
PRL concentrations in the media in the remaining patients were less than 10ng/ml. PRL concentrations in the media regressed more slowly than GH and still remained higher than 10ng/ml in all of the patients with high initial levels at 25-40 days when the studies were discontinued. In 2 of the 7 patients with low initial levels of PRL, PRL concentrations increased substantially during the study.
In one acromegalic patient (patient 5) with high in vitro PRL release in spite of completely normal preoperative plasma PRL level pituitary hormones other than GH were detected in high concentrations, while they were not detectable in another acromegalic patient (patient 6) examined as a control (Table 2) .
Discussion
When hormone concentrations are assayed by RIA in body fluids, tissue culture media or tissue extracts, nonspecific factors affecting the assay should be taken into consideration. Our results indicate that culture media did not affect the immunoreactivity of both GH and PRL.
The tissue culture technique has been used as one of the in vitro methods to investigate hormone secretion. It has advantages over the other in vitro methods in detecting a minute amount of hormone secretion and observing a sequential change in the hormone concentrations.
In the present study, all of the adenoma tissue obtained from acromegalic patients had marked GH release in vitro.
Besides, some PRL-secreting chromophobe adenoma without any clinical and endocrinological evidence of GH hypersecretion released significant amounts of GH in vitro. These observations suggest possibilities that some of the pituitary tumors without any clinical or endocrinological signs of hormone production are secreting subclinical amounts of hormones or secretory activities of endocrine tumors are not confined to a single hormone. Recent histochemical and electronmicroscopical observations by Corenblum et al.(1976) demonstrated that GHand RRL-secreting tumors secreted GH and PRL individually from mixed somatotrophic and lactotrophic adenomas. Alternatively, a possibility that two hormones are secreted from a single tumor cell cannot be denied. Comparative studies between morphological characteristics of the tumor cells and hormone-secreting activities should be needed for further discussion. Furthermore, a result obtained in one patient with acromegaly as shown in Table 2 suggest that an extreme care is necessary when adenoma tissues are proceeded to the culture. This particular patient was acromegalic with the normal plasma PRL level and underwent a trans-sphenoidal hypophysectomy.
In vitro PRL secretion in this patient seemed to be derived from the normal pituitary gland mixed with adenoma tissues because all of the anterior pituitary hormones were detected in the culture media.
All of the tumor tissues obtained from patients with hyperprolactinemia showed high in vitro PRL release. In some of these patients, plasma PRL was only slightly elevated to less than 40ng/ml before surgery. It could not be certain whether hyperprolactinemia in these patients were due to tumoral secretion or hypothalamic dysfunction by parasellar extension of the tumors before surgery. It has been stated that patients with PRL-secreting adenomas have very high plasma PRL levels often in excess of 500ng/ml, while PRL levels in hypothalamic disorders are characteristically low in those patients with PRLsecreting tumors. (Turkington, 1972) Our results indicate that PRL-secreting tumors cannot be ruled out in those patients with mild hyperprolactinemia of less than 40 ng/ml.
There are several earlier reports on measuring GH and PRL in the tissue culture media of pituitary adenoma as follows. In vitro GH secretion in acromegalic tumors have been reported to be high, but published results as to the duration of GH release have been variable. Kohler et al. (1969) observed a prolonged secretion for up to one year.
However, most other investigators such as Betzdorf et al. (1971) , Peillon et al. (1975) and Kageyama et al. (1976) reported the duration of GH secretion to be 2-4 weeks. Minute amounts of GH secretion have been reported by Kageyama et al. (1976) in some tumors from nonacromegalic patients, but the amount seemed to be too small to describe to tumoral secretions. Hwang et al. (1971) reported in vitro PRL secretion by an adenoma removed from a patient with galactorrhea. We observed that the duration of in vitro PRL release was longer than that of GH,. and that the decrease was slower. The duration and rate of hormone release in vitro would be influenced by the culture conditions or the dependency of the tumors on the hypothalamic regulation.
In the present experiment, the former factor was the same for both GH and PRL. As to the hypothalamic control, it has been demonstrated that PRL secretion in the normal subjects is under the tonic inhibitory control of PIF. Pasteel (1972) observed that PRL secretion from the normal pituitaries gradually increased in tissue cultures. It is not certain whether or not hypothalamic regulations in PRL-secreting tumors are in the same manner as in the normal subjects. Our results may suggest that at least some of the PRL-secreting pituitary tumors are under the inhibitory influences of the hypothalamus.
In conclusion, we demonstrated the in vitro secretion of GH in tissue cultures of pituitary adenoma obtained from patients with acromegaly and some patients with chromophobe adenoma with hyperprolactinemia.
Tumors obtained from patients with various degrees of hyperprolactinemia secreted PRL in vitro. It is suggested that PRL-secreting tumors could not be denied in patients with even mild hyperprolactinemia.
The duration of in vitro PRL release was longer than that of GH and. the rate of decrease was slower than that of GH.
